Please check your internet connection and try again.
# Urimax (tamsulosin)
## Overview
Tamsulosin is a selective alpha-1 adrenergic receptor antagonist that preferentially blocks alpha-1A receptors in the prostate and bladder neck, causing smooth muscle relaxation and improving urinary flow.
## Primary Indications
* Treatment of signs and symptoms of benign prostatic hyperplasia (BPH).
* Off-label: Medical expulsive therapy for ureteral calculi (kidney stones).
## Adult Dosing
* **BPH:** 0.4 mg orally once daily. If no response after 2–4 weeks, the dose may be increased to 0.8 mg orally once daily.
* **Ureteral Calculi (Off-label):** 0.4 mg orally once daily for up to 4 weeks.
## Pediatric Dosing
Not approved for use in the pediatric population. Safety and efficacy have not been established.
## Dose Adjustments
* **Renal Impairment:** No dosage adjustment necessary.
* **Hepatic Impairment:** Use with caution in patients with severe hepatic impairment; not studied in severe cases.
* **CYP3A4 Inhibitors:** If initiated in patients already taking strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin), dose should not exceed 0.4 mg.
## Contraindications
* Known hypersensitivity to tamsulosin or any component of the formulation.
## Adverse Effects
* **Common:** Dizziness, headache, abnormal ejaculation (retrograde ejaculation), rhinitis, and orthostatic hypotension.
* **Serious:** Intraoperative Floppy Iris Syndrome (IFIS) during cataract surgery, syncope, severe allergic reactions (angioedema, urticaria).
## Key Drug Interactions
* **PDE5 Inhibitors (e.g., sildenafil, tadalafil):** Concomitant use may increase the risk of symptomatic hypotension.
* **Strong CYP3A4 Inhibitors:** May significantly increase plasma concentrations of tamsulosin.
* **Antihypertensives:** May enhance the hypotensive effect of alpha-blockers.
## Monitoring
* Monitor blood pressure periodically, especially following the initial dose or a dose escalation (risk of orthostatic hypotension).
* Assess for relief of BPH symptoms (e.g., IPSS score).
* During physical exams, monitor for signs of prostate cancer, which can mimic BPH.
## Clinical Pearls
* **Administration:** Administer 30 minutes after the same meal each day to ensure bioavailability. Do not crush, chew, or open the capsule.
* **Cataract Surgery:** Advise patients to inform their ophthalmologist of current or prior tamsulosin use, as it significantly increases the risk of IFIS.
* **Syncope:** Counsel patients on the risk of dizziness/fainting upon standing ("first-dose phenomenon"), particularly when starting or increasing the dose.
* **Efficacy:** Unlike 5-alpha-reductase inhibitors (e.g., finasteride), tamsulosin does not reduce prostate size or PSA levels.
***
*Disclaimer: This information is for educational purposes only. Clinical practice guidelines and local protocols may vary. Always verify current prescribing information, contraindications, and drug interactions via a reliable clinical database (e.g., Lexicomp, UpToDate) before prescribing or administering medication.*
